X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4066) 4066
Publication (413) 413
Book Review (57) 57
Newsletter (36) 36
Book Chapter (28) 28
Dissertation (4) 4
Book / eBook (2) 2
Newspaper Article (2) 2
Reference (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2394) 2394
animals (2181) 2181
humans (1846) 1846
male (1695) 1695
angiotensin (1398) 1398
hypertension (1176) 1176
rats (1147) 1147
female (821) 821
angiotensin ii (759) 759
pharmacology & pharmacy (713) 713
biochemistry & molecular biology (711) 711
angiotensin-ii (630) 630
mice (603) 603
angiotensin ii type 1 receptor blockers - pharmacology (597) 597
renin-angiotensin system (594) 594
cell biology (553) 553
middle aged (534) 534
oxidative stress (528) 528
blood pressure (521) 521
physiology (507) 507
rodents (464) 464
blood pressure - drug effects (456) 456
blood-pressure (438) 438
expression (420) 420
medicine (417) 417
hypertension - drug therapy (414) 414
rats, sprague-dawley (406) 406
research (399) 399
aged (373) 373
diabetes (372) 372
proteins (370) 370
enzymes (361) 361
adult (352) 352
receptor, angiotensin, type 1 - metabolism (352) 352
research article (349) 349
analysis (347) 347
inflammation (347) 347
angiotensin ii - pharmacology (345) 345
activation (343) 343
rats, wistar (325) 325
angiotensin ii - metabolism (315) 315
heart failure (315) 315
losartan - pharmacology (315) 315
physiological aspects (312) 312
risk factors (308) 308
losartan (305) 305
renin (305) 305
signal transduction (305) 305
tetrazoles - pharmacology (300) 300
peripheral vascular disease (298) 298
gene expression (296) 296
renin-angiotensin system - drug effects (289) 289
cells, cultured (286) 286
angiotensin ii type 1 receptor blockers - therapeutic use (283) 283
biology (280) 280
cardiology (278) 278
multidisciplinary sciences (277) 277
endocrinology & metabolism (276) 276
fibrosis (275) 275
angiotensin-converting enzyme inhibitors - therapeutic use (273) 273
antihypertensive agents - therapeutic use (273) 273
health aspects (272) 272
receptor (271) 271
hypertension - physiopathology (267) 267
disease models, animal (266) 266
science (266) 266
biochemistry (262) 262
system (260) 260
inhibition (257) 257
heart (256) 256
cardiac & cardiovascular systems (255) 255
valsartan (253) 253
article (247) 247
antihypertensive agents - pharmacology (242) 242
medicine, research & experimental (238) 238
dose-response relationship, drug (236) 236
angiotensin-converting enzyme inhibitors - pharmacology (233) 233
apoptosis (227) 227
drug therapy (227) 227
review (224) 224
biochemistry, general (222) 222
kinases (222) 222
treatment outcome (219) 219
benzimidazoles - pharmacology (218) 218
mice, inbred c57bl (211) 211
medicine & public health (210) 210
time factors (210) 210
care and treatment (209) 209
angiotensin-converting enzyme (208) 208
life sciences (208) 208
phosphorylation (208) 208
mortality (205) 205
pharmacology (205) 205
aldosterone (204) 204
chemistry, medicinal (203) 203
heart-failure (202) 202
renin-angiotensin system - physiology (202) 202
nitric oxide (201) 201
angiotensin ii type 1 receptor blockers - chemistry (200) 200
receptors (199) 199
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 08/2016, Volume 97, pp. 180 - 190
Journal Article
Nature, ISSN 0028-0836, 04/2017, Volume 544, Issue 7650, pp. 327 - 332
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 06/2011, Volume 54, Issue 12, pp. 4219 - 4233
Journal Article
Cell, ISSN 0092-8674, 05/2015, Volume 161, Issue 4, pp. 833 - 844
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 35, Issue 29, pp. 8450 - 8466
Abstract A multifunctional copolymer–anticancer conjugate chitosan-graft-polyethyleneimine-candesartan (CPC) containing low molecular weight chitosan (CS)... 
Advanced Basic Science | Dentistry | Wild type p53 | Co-delivery | Candesartan | Angiotensin II type 1 receptor targeting | Multifunctional copolymer–anticancer conjugate | Tumor anti-angiogenesis therapy | Multifunctional copolymer-anticancer conjugate | MATERIALS SCIENCE, BIOMATERIALS | SOLID TUMORS | ENGINEERING, BIOMEDICAL | II TYPE-1 RECEPTOR | TRANSFECTION EFFICIENCY | ANGIOTENSIN-SYSTEM | TUMOR ANGIOGENESIS | HUMAN BREAST-CANCER | DOUBLE-WALLED MICROSPHERES | CELL-DEATH | ADMINISTRATION IN-VIVO | ENDOTHELIAL GROWTH-FACTOR | Neoplasms - metabolism | Genetic Therapy | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | DNA - therapeutic use | Male | Benzimidazoles - chemistry | Angiotensin II Type 1 Receptor Blockers - metabolism | Drug Delivery Systems | Tetrazoles - metabolism | Genes, p53 | Neoplasms - therapy | Benzimidazoles - administration & dosage | Neoplasms - genetics | Tetrazoles - chemistry | Tetrazoles - administration & dosage | Polyethyleneimine - chemistry | Chitosan - analogs & derivatives | Chitosan - metabolism | Neovascularization, Pathologic - therapy | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Benzimidazoles - therapeutic use | Gene Transfer Techniques | Polyethyleneimine - metabolism | Angiotensin II Type 1 Receptor Blockers - chemistry | DNA - administration & dosage | Neoplasms - blood supply | DNA - genetics | Polyethyleneimine - analogs & derivatives | Animals | Chitosan - chemistry | Benzimidazoles - metabolism | Receptor, Angiotensin, Type 1 - metabolism | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Tetrazoles - therapeutic use | Mice, Inbred BALB C | RNA | Political corruption | Genes | Analysis | Angiotensin | Genetic research | Genetic aspects | Pharmaceutical industry | Tumor proteins | Health aspects | Vascular endothelial growth factor | Cancer | Drugs | Therapy | Cadmium | Nanostructure | Buffers | Density | Tumors
Journal Article
Journal Article